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Abstract
Background: In the perioperative period, it may be inappropriate to monitor vital signs during endotracheal intubation
using the same interval as during a hemodynamically stable period. The aim of the present study was to determine
whether it is appropriate to use the same intervals used during the endotracheal intubation and stable periods to monitor
vital signs of patients under general anesthesia.
Methods: The mean arterial pressure (MAP) and heart rate (HR) were continuously measured during endotracheal
intubation (15 min after intubation) and hemodynamically stable (15 min before skin incision) periods in 24 general
anesthesia patients. Data was considered “unrecognized” when continuously measured values were 30% more or less
than the monitored value measured at 5- or 2.5-min intervals. The incidence of unrecognized data during endotracheal
intubation was compared to that during the hemodynamically stable period.
Result: There were significantly more unrecognized MAP data measured at 5-min intervals during endotracheal intubation
than during the hemodynamically stable period (p value <0.05). However, there was no difference in the incidence of
unrecognized MAP data at 2.5 min intervals or HR data at 5 or 2.5 min intervals between during the endotracheal
intubation and hemodynamically stable periods.
Conclusion: A 5-min interval throughout the operation period was not appropriate for monitoring vital signs. Therefore,
, a 2.5-min interval is recommended for monitoring the MAP during endotracheal intubation.
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Background
Monitoring vital signs such as mean arterial pressure
(MAP), heart rate (HR), respiratory rate, and body
temperature during the perioperative period is important
for reviewing the hemodynamic status of patients and
for planning future treatments [1–3]. Monitored vital
signs are also used as basic data for clinical studies and
malpractice trials [4–9]. Shorter monitoring intervals
allow for vital signs to make greater contributions to-
ward determining patients’ vital sign trends [10, 11]. On
the other hand, short intervals demand significant time
and effort from the anesthesiologist. According to the
American Society of Anesthesiologists (ASA) guidelines
and clinical conventions, anesthesiologists tend to moni-
tor vital signs at 5-min intervals during the perioperative
period. The 5-min interval for monitoring vital signs can
be appropriate when patients are hemodynamically stable.
However, when patients are hemodynamically unstable,
this interval may be insufficient to accurately assess rap-
idly changing hemodynamics [10, 12]. Endotracheal intub-
ation is a hemodynamic-stimulant procedure that can
cause abrupt changes in the vital signs of patients. How-
ever, the interval for monitoring vital signs is usually con-
stant throughout the perioperative period. We believe it
would be more appropriate to make the interval change
during endotracheal intubation. The aim of this study was
to compare the appropriateness of different intervals for
monitoring vital signs in the same patients during endo-
tracheal intubation and hemodynamically stable periods.
Methods
This study was approved by the institutional review
board, and informed consent was obtained from sub-
jects. The study was prospectively conducted on 25 adult
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patients who were 20–60 years old, had either ASA phys-
ical status I or II, and were undergoing general anesthesia
for elective surgery. Patients with cardiovascular, respira-
tory, and cerebral disorders were excluded. Patients antici-
pated to have difficulties with mask ventilation or
intubation (cervical spine disease, limited mouth opening
and neck extension, pharyngeal pathology, or history of
difficult intubation) were also excluded. Fluid was infused
intravenously as per the weight of the patients during Non
Per Os time to prevent hypovolemia. Midazolam 2–3 mg
and Glycopyrrolate 0.5 mg were administered intraven-
ously as premedication. All patients were monitored with
an electrocardiogram, pulse oximeter, non-invasive blood
pressure, capnography, bispectral index (BIS), and neuro-
muscular monitoring upon arrival in the operating room.
After lidocaine infiltration, a right radial arterial catheter
(BD Arterial Cannula, BD Infusion Therapy Systems Inc.,
Utah, USA) was inserted, and arterial pressure was mea-
sured continuously for every patient. Baseline vital signs
were defined as the values measured immediately before
anesthetic induction. After 1 mg/kg of lidocaine was ad-
ministered intravenously, anesthesia was induced with
propofol (4 mcg/ml of effect-site concentration) and remi-
fentanil (3 ng/ml of effect-site concentration) using target-
controlled infusion (Minto model for remifentanil). The
effect-site concentrations of propofol (2–5 mcg/ml) and
remifentanil (2–5 ng/ml) were adjusted by 1 mcg/ml or
1 ng/ml of the effective-site concentration at 2-min inter-
vals to maintain a target range for BIS (45–60) and MAP
within ±30% of the respective baseline values. The effect-
site concentrations of propofol and remifentanil were
monitored every minute during the endotracheal intub-
ation and stable periods. Three minutes later, rocuronium
bromide (0.6 mg/kg) was administered, and neuromuscu-
lar blockade was confirmed using a train-of-four (TOF)
stimulation count (TOF = 0). The trachea was intubated,
and the lungs were mechanically ventilated to maintain
normocarbia. During the perioperative period, MAP and
HR were maintained according to standard protocols. Res-
cue medication was administered when MAP and HR
could not be maintained by adjusting the effect-site con-
centration of remifentanil (2–5 ng/ml) or when immediate
treatment was needed due to severe abnormal vital signs
that indicated a compromised hemodynamic status. If the
MAP increased or decreased by more than 30% of the
baseline value, a single bolus of nicardipine (300 mcg) or
phenylephrine (100 mcg) was given at 3-min intervals up
to three times. If the HR increased or decreased by more
than 30% of the baseline value despite maintenance of the
MAP, a single bolus of esmolol (10 mg) or atropine sulfate
(0.5 mg) was given at 3-min intervals up to three times. If
MAP and HR were not maintained within 30% of the
baseline value despite three administrations of rescue
medication, the patient was removed from the present
study and received proper treatment such as fluid and
inotropics [13–16].
Collection and analysis of vital signs
We collected and analyzed MAP and HR because re-
spiratory rate and body temperature are relatively con-
stant during anesthesia. The monitor calculated beat-
per-beat values for MAP and HR and displayed the
mean values over the previous 2 s on the screen. Data
was automatically downloaded from the monitor (GE
MARQUETTE SOLAR 8000 M, GE MEDICAL SYS-
TEMS INFORMATION TECHNOLOGIES, Milwaukee,
USA) to a personal computer using an RS-232C inter-
face throughout the entire perioperative period at 1-s in-
tervals. With the exception of BIS recorded at 10-s
intervals, measured vital signs recorded at 1-s intervals
were collected and analyzed. The endotracheal intub-
ation period and hemodynamically stable period were
defined as 15 min after endotracheal intubation and
15 min before skin incision, respectively. During both
periods, any procedure that influenced the monitoring
of vital signs, such as vascular cannulation and foley
catheter insertion, was prohibited. For 5-min monitoring
intervals, values were monitored at six time points (2.5,
7.5, and 12.5 min after intubation and 12.5, 7.5, and
2.5 min before skin incision). For 2.5-min intervals,
values were monitored at 12 time points (1.25, 3.75,
6.25, 8.75, 11.25, and 13.75 min after intubation and
13.75, 11.25, 8.75, 6.25, 3.75, and 1.25 min before skin
incision). For example, for the 5-min interval, the mea-
sured value at 2.5 min after intubation was considered
the monitored value and represented the values mea-
sured immediately to 5 min after intubation. Measured
values were defined as ‘unrecognized data’ when they
were 30% more or less than the monitored value. The
incidence of unrecognized data in this study may corres-
pond to unrecognized periods when vital signs were 30%
more or less than the monitored vital signs measured at
5- or 2.5-min intervals.
Statistical analysis
We performed a pilot study involving 10 patients and
measured the incidence of unrecognized data for the
MAP in each patient. The results of the pilot study
showed a mean difference ± SD (%) of 7.1 ± 8.6% in the
incidence of unrecognized data for the MAP between the
endotracheal intubation and hemodynamically stable pe-
riods. The required sample size, calculated with 95%
power and α = 0.05 using a paired t-test, was a minimum
of 22 participants. Assuming a potential dropout rate of
10%, 25 participants were recruited for the present study.
Using 5- or 2.5-min intervals to monitor vital signs, the
mean incidence of unrecognized data for MAP and HR
were compared using a paired t-test between the
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endotracheal intubation and hemodynamically stable pe-
riods. Bonferroni’s method was used to correct for mul-
tiple comparisons. The data is expressed as mean ± SD, as
median and interquartile range, and as proportions or
counts, based on the data’s characteristics. Comparisons
were considered statistically significant when the p value
was <0.05.
Results
A total of 25 patients undergoing lumbar spinal fusion
were enrolled in this study. The vital signs of 24 patients
were analyzed, as one patient was dropped from the study
due to uncontrolled blood pressure despite three injec-
tions of rescue medicine. The demographic characteristics
of patients are shown in Table 1. And the time interval
(mean ± SD) between the endotracheal intubation periods
and the stable periods was 41.7 ± 15.4 min. Figure 1 shows
the vital sign trends during the endotracheal intubation
period and the hemodynamically stable period. During
endotracheal intubation, the differences between the max-
imal and minimal MAP and HR (mean ± SD) for each pa-
tient were 31.8 ± 20.7 mmHg and 34.9 ± 12.5 per min,
respectively. During the hemodynamically stable period,
the differences were 17.2 ± 11.3 mmHg and 14.6 ± 15.3
per min, respectively. The incidence of unrecognized data
in this study may correspond to unrecognized periods
when vital signs were 30% more or less than the moni-
tored vital signs measured at 5- or 2.5-min intervals. Sig-
nificantly high incidence of unrecognized data for the
MAP with 5-min intervals was showed during the endo-
tracheal intubation period compared to during the
hemodynamically stable period. However, there were no
differences between the two periods in the incidence of
unrecognized data for the MAP with 2.5-min intervals.
(Table 2) The incidence of unrecognized data for the HR
was also no different for either time interval. When a 30%
difference was observed based on the baseline, patients
were injected with appropriate drugs as shown in Table 3.
Discussion
During endotracheal intubation, vital signs can change
rapidly and widely despite various efforts to reduce the
changes by the anesthesiologist. Abrupt changes in vital
signs can induce critical cardiovascular complications
such as cerebral stroke, angina, and myocardial infarction.
During endotracheal intubation, vital sign monitoring is
clinically important, particularly in patients susceptible to
cardiovascular complications. Although there have been a
few studies that evaluated adequate time intervals for
monitoring vital signs during the perioperative period,
these studies did not focus on endotracheal intubation
[10–12]. There has been no research on the appropriate
time interval for monitoring vital signs during endo-
tracheal intubation, although the latter induces a
hemodynamic response that can cause serious cardiovas-
cular complications. To our knowledge, this is the first
study that focuses on finding the appropriate time inter-
vals for monitoring vitals during endotracheal intubation.
In the present study, at 5-min intervals, there was a
higher incidence of unrecognized MAP data when moni-
toring vital signs during the endotracheal intubation period
than when monitoring during the hemodynamically stable
period. At 2.5-min intervals, there were no differences in
the incidence of unrecognized data between the endo-
tracheal intubation and the hemodynamically stable pe-
riods. Thus, 2.5-min intervals are recommended for
monitoring vital signs in order to reduce the incidence of
unrecognized data during endotracheal intubation.
Sympathetic stimulus caused by tracheal intubation can
be different based on various factors related to anesthesia
and tracheal intubation. To reduce the diversity of pa-
tients’ hemodynamic responses to sympathetic stimula-
tion, we used the same anesthetic method, including the
anesthetic drug, tracheal intubation technique, and proto-
col for controlling vital signs. Anesthetics, propofol and
remifentanil, were administered using target-controlled in-
fusion to reduce the possibility of inter-individual variabil-
ity. Remifentanil was given as an opioid analgesic to every
patient to decrease excessive increases in MAP and HR.
Tracheal intubations were performed by a single expe-
rienced anesthesiologist.
The present study focused on the appropriate time inter-
val for monitoring vital signs during endotracheal intub-
ation. During general anesthesia, there can be various types
of hemodynamically unstable periods, such as during skin
incision, extubation, or massive bleeding. The results of the
present study can be applied to other hemodynamically un-
stable periods during general anesthesia if the trend and
range of the vital signs are similar to those of the present
study. In this study, the differences between the maximal
and minimal MAP and HR (mean ± SD) of each patient
were 31.8 ± 20.7 mmHg and 34.9 ± 12.5 per min, respect-
ively, during tracheal intubation. During perioperative pe-
riods showing a more severe change in vital signs than in
the present study, the time interval for monitoring vital
signs should be shorter than 2.5 min. However, monitoring
arterial pressure using non-invasive blood pressure at 1-
min intervals or using an intra-arterial catheter might
cause complications such as an injury to the nerve or an is-
chemia of the extremes.
Table 1 Demographic characteristics of patients
Sex (male/female) 13/11
Age (years) 50.8 ± 5.4
Height (cm) 165.3 ± 9.9
Weight (kg) 59.5 ± 13.6
Values are expressed as mean ± SD or number
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The incidence of unrecognized data in this study may
correspond to unrecognized periods when vital signs
were 30% more or less than the monitored vital signs
measured at 5- or 2.5-min intervals. A higher frequency
of 30% variations indicates that patients spend more
time with abnormal vital signs. In the present study, at
5-min intervals during endotracheal intubation, the
MAP of patients was more than 30% different from the
monitored vital signs for 71 s. In healthy patients, 71 s
of abnormal vital signs is unlikely to induce critical com-
plications. However, in high-risk patients (e.g., the eld-
erly with cardiovascular diseases) rapid changes in vital
signs may produce serious complications [1, 17, 18]. Fur-
thermore, in this study, invasive arterial line monitoring
was performed to continuously monitor the vital signs.
When a 30% difference was observed based on the base-
line, patients were injected with appropriate drugs as
shown in Table 3 and their vital signs were normalized.
However, if hemodynamic changes that require active
treatments occur and are not treated, the duration of
unrecognized periods may be longer and affect the clin-
ical outcome of patients. At 5-min intervals during
hemodynamically stable periods and at 2.5-min intervals
during endotracheal intubation periods and stable
Fig. 1 Monitored MAP and HR during the two periods for the 2.5-min-interval group
Table 2 Incidences (%) of unrecognized data monitorings of vital signs
Supposed time interval Vital signs Endotracheal intubation Hemodynamically stable period p-value
5 min MAP 7.9 ± 8.2 2.1 ± 3.8 0.006
HR 5.1 ± 6.7 2.4 ± 4.2 0.058
2.5 min MAP 2.5 ± 3.1 1.2 ± 2.2 0.065
HR 1.9 ± 2.5 1.7 ± 3.2 0.772
MAP and HR mean mean arterial pressure and heart rate respectively
Values are expressed as mean ± SD
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periods, the incidence of unrecognized data (<25 s) was
too low to produce a clinical effect.
In clinical practice, anesthesiologists measure vital
signs continuously using intra-arterial catheters when
rapid changes in vital signs are predicted or observed
during the perioperative period. However, guidelines for
establishing the intervals of monitoring vital signs during
ordinary perioperative events, such as endotracheal in-
tubation, are still necessary, as endotracheal intubation
can cause unpredicted rapid changes in vital signs even
in healthy patients. Furthermore, patients may have un-
diagnosed underlying diseases that may cause a sudden
change in vital signs. When rapid changes in vital sign
are recognized in a patient without continuous monitor-
ing, shortening the interval for measuring vital signs can
facilitate early detection of cardiovascular complications,
as per the results of the present study.
The present study had several limitations. First, pa-
tients in this study were healthy and young. Applying
our results to elderly patients or individuals with cardio-
vascular disease should be done with caution. Second,
MAP and HR during anesthesia are influenced by the
anesthetic method, including anesthetic drugs, intub-
ation technique, and the protocol for managing MAP
and HR. If a different anesthetic method had been used,
vital signs and the incidence of unrecognized data may
have been different from those of the present study.
Third, the MAP was monitored and managed based on
data obtained from continuous monitoring with an
intra-arterial catheter. If the MAP were measured using
a non-invasive blood pressure monitor with 2.5- or 5-
min intervals, the change in vital signs could have been
greater than that observed in the present study. This
may have resulted in a higher incidence of unrecognized
data than found in the present study.
Conclusion
Our data suggests that vital sign abnormalities may be ac-
curately identified by more frequent measurement during
endotracheal intubation. During endotracheal intubation,
5-min intervals may be inappropriate for monitoring vital
signs. To reduce the incidence of unrecognized data, 2.5-
min intervals are recommended for monitoring the MAP
during endotracheal intubation.
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